JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1677/jme.0.0260217
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xie, W
Right arrow Articles by Safe, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xie, W
Right arrow Articles by Safe, S
Journal of Molecular Endocrinology, Vol 26, Issue 3, 217-228
Copyright © 2001 by Society for Endocrinology

Articles

Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor alpha crosstalk

W Xie, R Duan, and S Safe


Adenosine deaminase (ADA) regulates cellular levels of adenosine and deoxyadenosine, and 17beta-estradiol (E(2)) induces ADA mRNA in MCF-7 human breast cancer cells. IGF-I also induces ADA gene expression in these cells, and induction of this response through IGF activation of estrogen receptor alpha (ERalpha) was further investigated. IGF and other polypeptide growth factors induce reporter gene expression in MCF-7 cells cotransfected with ERalpha expression plasmid and pADA211, a construct containing the -211 to +11 region of the ADA gene promoter which is required for high basal and E(2)-inducible activity. Deletion analysis of this promoter demonstrates that IGF activates ERalpha/Sp1 interactions with multiple GC-rich sites in the promoter and this response is abrogated in cells transfected with ERalpha containing mutations at Ser(118) or Ser(163). IGF induces both MAPK (mitogen-activated protein kinase) and PI3-K (phosphatidylinositol-3-kinase) phosphorylation cascades in MCF-7 cells; however, using a series of inhibitors and dominant negative constructs, our results show that induction of ADA by IGF activation of ERalpha/Sp1 is dependent on the MAPK signaling pathway.


This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
S Zhang, X Li, R Burghardt, R Smith III, and S H Safe
Role of estrogen receptor (ER) {alpha} in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells
J. Mol. Endocrinol., December 1, 2005; 35(3): 433 - 447.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. Li, Y.-H. Chen, T.-J. Liu, J. Jia, S. Hampson, Y.-X. Shan, D. Kibler, and P. H. Wang
Using DNA Microarray to Identify Sp1 as a Transcriptional Regulatory Element of Insulin-Like Growth Factor 1 in Cardiac Muscle Cells
Circ. Res., December 12, 2003; 93(12): 1202 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
R. Simstein, M. Burow, A. Parker, C. Weldon, and B. Beckman
Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System
Experimental Biology and Medicine, October 1, 2003; 228(9): 995 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Tang, D. Zhang, L. Fallavollita, and P. Brodt
Vascular Endothelial Growth Factor C Expression and Lymph Node Metastasis Are Regulated by the Type I Insulin-like Growth Factor Receptor
Cancer Res., March 15, 2003; 63(6): 1166 - 1171.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.